DBP International: Dossier for Inofer acquired
In 2019 a clinical study was conducted in a collaboration between Double Bond Pharmaceutical AB (“Double Bond”) and Skellefteå Lasarett. The study showed that iron succinate significantly improves iron uptake, iron saturation and iron storage in patients with heart failure and iron deficiency. Today, December 7 2020 Double Bond and Laboratorie X.O (France) signed an agreement for the acquisition and rights of Inofer[©]´s (iron succinate) registration dossier for the Nordic market. "We are pleased with the positive clinical results of ferrous succinate´s use. We strongly believe in the